References
- Kim M, Kang SY, Yang SI, Lee IH, Ryu G, Kim MA, et al. KAAACI Allergic Rhinitis Guidelines: Part 1. Update in pharmacotherapy. Allergy Asthma Respir Dis 2023;11:117-25.
- Yang SI, Lee IH, Kim M, Ryu G, Kang SY, Kim MA, et al. KAAACI Allergic Rhinitis Guidelines: Part 1. Update in pharmacotherapy. Allergy Asthma Immunol Res 2023;15:19-31.
- Park SC, Chung SJ, Choi JH, Lee YJ, Yang HJ, Park DY, et al. KAAACI Allergic Rhinitis Guidelines: Part 2. Update in nonpharmacotherapy. Allergy Asthma Respir Dis 2023;11:126-34.
- Park DY, Lee YJ, Kim DK, Kim SW, Yang HJ, Kim DH, et al. KAAACI Allergic Rhinitis Guidelines: Part 2. Update in non-pharmacological management. Allergy Asthma Immunol Res 2023;15:145-59.
- Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:1253-61.
- Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:45-53.
- Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012;157:288-98.
- Kim JY, Jang MJ, Kim DY, Park SW, Han DH. Efficacy of subcutaneous and sublingual immunotherapy for house dust mite allergy: a network meta-analysis-based comparison. J Allergy Clin Immunol Pract 2021;9:4450-8.e6.
- Chung SJ, Sim JA, Kim HB, Park DY, Choi JH. Head-to-head comparison between subcutaneous and sublingual immunotherapy in perennial allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Respir Dis 2024;12:17-25.